Clinical Trial Update: Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial) [Phase 3]

View source ↗

Summary

Nivolumab is being studied after surgery and chemotherapy in stage IB to IIIA non-small cell lung cancer as part of the ALCHEMIST Treatment Trial (Phase 3). The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7 | Phase 3 | Status: ACTIVE_NOT_RECRUITING